Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Eur Radiol ; 9(5): 951-8, 1999.
Article in English | MEDLINE | ID: mdl-10369999

ABSTRACT

The Amplatz Thrombectomy Device (ATD) is a percutaneous, rotational thrombectomy catheter, capable of recirculating and homogenizing the thrombus in order to obtain mechanical clot dissolution. The authors present their experience with mechanical thrombectomy with the ATD in eight cases of ilio-caval thrombosis. Under temporary caval filter protection, the ATD was introduced through the right transjugular approach (in one patient this was used in combination with the right femoral approach) and activated for a time ranging from 90 to 180 s. Complete clearing of thrombotic material in the treated venous segments was achieved in six cases (75 %), partial success was obtained in one case (12.5 %) and failure occurred in one patient (12.5 %). One patient developed a recurrence of venous iliac thrombosis 1 week after the procedure and postphlebitic syndrome 6 months after the first episode of deep venous thrombosis, and one patient died from acute myocardial infarction, unrelated to thrombectomy session, after 3 days. A negative clinical and radiological follow-up at 3, 6, 12 and 24 months was obtained in the remaining six patients. If a fresh free-floating ilio-caval clot must be removed immediately, the ATD can be effective under temporary filter protection.


Subject(s)
Catheterization , Iliac Vein , Thrombectomy/instrumentation , Vena Cava, Inferior , Venous Thrombosis/therapy , Adult , Aged , Female , Humans , Iliac Vein/diagnostic imaging , Male , Middle Aged , Radiography, Interventional , Thrombectomy/adverse effects , Thrombectomy/methods , Vena Cava, Inferior/diagnostic imaging , Venous Thrombosis/diagnostic imaging
3.
Eur Radiol ; 6(2): 230-5, 1996.
Article in English | MEDLINE | ID: mdl-8797986

ABSTRACT

The purpose of this study was to evaluate technical and clinical results of self-expanding esophageal stent implanted in patients with malignant esophageal strictures and clinically significant dysphagia. From June 1992 to September 1994, 27 patients with inoperable tumors of the esophagus or gastric cardiac were treated by placement of 37 self-expanding nitinol stents. Water-soluble contrast and endoscopy studies were performed after the procedure and during the follow-up period. Successful stenting of the stricture was achieved in 27 patients. The mean dysphagia grade dropped from 2.3 to 1 (SD +/- 0.54) immediately after the procedure. After the insertion of the stent, 16 patients died in a period of time ranging from 0 to 13 months (mean 5.6 months), whereas at the end of the study 11 patients were alive 4-15 months after the procedure (mean 8.3 months). No major complications were observed. The results of this study are encouraging because esophageal stent placement was technically easy and clinically effective.


Subject(s)
Alloys , Esophageal Neoplasms/complications , Esophageal Stenosis/therapy , Palliative Care , Stents , Adenocarcinoma/complications , Aged , Carcinoma, Squamous Cell/complications , Cardia , Catheterization , Contrast Media , Deglutition Disorders/etiology , Deglutition Disorders/therapy , Equipment Design , Esophageal Stenosis/diagnostic imaging , Esophageal Stenosis/etiology , Esophagoscopy , Female , Fluoroscopy , Follow-Up Studies , Humans , Male , Radiography, Interventional , Retrospective Studies , Solubility , Stomach Neoplasms/complications , Survival Rate , Water
SELECTION OF CITATIONS
SEARCH DETAIL
...